Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Schriefer

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Frontiers in Digital Health|October 20, 2025
From implementation to discontinuation: multi-year experience with the multiple sclerosis performance test as a digital monitoring toolDirk Schriefer, Anja Dillenseger, Yassin Atta, et al.
Biomedicines|March 29, 2023
Countermovement Jumps Detect Subtle Motor Deficits in People with Multiple Sclerosis below the Clinical ThresholdAnne Geßner, Heidi Stölzer-Hutsch, Katrin Trentzsch, et al.
Scientific Reports|September 17, 2025
Phenotyping and characterising gait profiles of people with multiple sclerosisKatrin Trentzsch, Dirk Schriefer, Heidi Stölzer-Hutsch, et al.
Pharmacoeconomics|May 5, 2020
Real-World Evidence on the Societal Economic Relapse Costs in Patients with Multiple SclerosisNils-Henning Ness, Dirk Schriefer, Rocco Haase, et al.
Pharmacoeconomics|May 15, 2020
Correction to: Real-World Evidence on the Patterns of Increased Societal Economic Relapse Costs in Patients with Multiple SclerosisNils-Henning Ness, Dirk Schriefer, Rocco Haase, et al.
Preventive Medicine Reports|February 18, 2017
Participation in preventive health check-ups among 19,351 women in GermanyStefanie Schülein, Katherine J Taylor, Dirk Schriefer, et al.
Plos One|July 14, 2021
Impact of opportunistic screening on squamous cell and adenocarcinoma of the cervix in Germany: A population-based case-control studyLuana F Tanaka, Dirk Schriefer, Kathrin Radde, et al.
Biomedicines|May 25, 2024
The Association of Age, Sex, and BMI on Lower Limb Neuromuscular and Muscle Mechanical Function in People with Multiple SclerosisAnne Geßner, Maximilian Hartmann, Katrin Trentzsch, et al.
Journal of Neurology|December 19, 2019
Differentiating societal costs of disability worsening in multiple sclerosisNils-Henning Ness, Dirk Schriefer, Rocco Haase, et al.
Journal of Neurology|January 17, 2025
Cost-consequence analysis of early vs. delayed natalizumab use in highly active relapsing-remitting multiple sclerosis: a simulation studyHernan Inojosa, Dirk Schriefer, Nils-Henning Ness, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Frontiers in Digital Health|October 20, 2025
From implementation to discontinuation: multi-year experience with the multiple sclerosis performance test as a digital monitoring toolDirk Schriefer, Anja Dillenseger, Yassin Atta, et al.
Biomedicines|March 29, 2023
Countermovement Jumps Detect Subtle Motor Deficits in People with Multiple Sclerosis below the Clinical ThresholdAnne Geßner, Heidi Stölzer-Hutsch, Katrin Trentzsch, et al.
Scientific Reports|September 17, 2025
Phenotyping and characterising gait profiles of people with multiple sclerosisKatrin Trentzsch, Dirk Schriefer, Heidi Stölzer-Hutsch, et al.
Pharmacoeconomics|May 5, 2020
Real-World Evidence on the Societal Economic Relapse Costs in Patients with Multiple SclerosisNils-Henning Ness, Dirk Schriefer, Rocco Haase, et al.
Pharmacoeconomics|May 15, 2020
Correction to: Real-World Evidence on the Patterns of Increased Societal Economic Relapse Costs in Patients with Multiple SclerosisNils-Henning Ness, Dirk Schriefer, Rocco Haase, et al.
Preventive Medicine Reports|February 18, 2017
Participation in preventive health check-ups among 19,351 women in GermanyStefanie Schülein, Katherine J Taylor, Dirk Schriefer, et al.
Plos One|July 14, 2021
Impact of opportunistic screening on squamous cell and adenocarcinoma of the cervix in Germany: A population-based case-control studyLuana F Tanaka, Dirk Schriefer, Kathrin Radde, et al.
Biomedicines|May 25, 2024
The Association of Age, Sex, and BMI on Lower Limb Neuromuscular and Muscle Mechanical Function in People with Multiple SclerosisAnne Geßner, Maximilian Hartmann, Katrin Trentzsch, et al.
Journal of Neurology|December 19, 2019
Differentiating societal costs of disability worsening in multiple sclerosisNils-Henning Ness, Dirk Schriefer, Rocco Haase, et al.
Journal of Neurology|January 17, 2025
Cost-consequence analysis of early vs. delayed natalizumab use in highly active relapsing-remitting multiple sclerosis: a simulation studyHernan Inojosa, Dirk Schriefer, Nils-Henning Ness, et al.
Pageof 4